MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
The UK government has announced a new National Genomic Healthcare Strategy which sets out how the UK can become the global leader in genomic healthcare.
The UK's Department for Health is launching NHSX, a new unit with responsibility for setting national policy and developing best practice for NHS technology.
Inovia Capital, the Canadian VC firm, has raised two new funds totalling US$600 million: an early-stage fund of $200 million; and a growth-stage of $400 million. The funds will be invested in its existing markets in Canada and Silicon Valley, as well as through a new office in London.
NHS England wants to catch lung cancer before it's too late with the roll-out of mobile scanning units. £70 million is going to fund ten projects to check people at highest risk.
Genomics England has selected QIAGEN to provide bioinformatic support to the NHS Genomic Medicine Service and its national network of Genomic Laboratory Hubs for 5 million genome project.
Constrained by workforce shortages during the difficult winter period, Dartford and Gravesham NHS Trust deployed Current, an AI-enabled wearable platform, to remotely monitor patients after being discharged from hospital.
Prenetics, the genetic screening company, has acquired Soma Analytics, the developer of workplace stress relief app Kelaa.
The UK's National Health Service (NHS) has begun the public rollout of the NHS app, which provides online access to NHS services.
A collaboration between Aether, the Californian bioprinter startup, and University College London (UCL) promises to develop a powerful new approach to 3D printing nanotechnology, while greatly reducing the cost compared with competitor offerings.